Halozyme Therapeutics logo
Halozyme Therapeutics HALO
$ 49.38 8.05%

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Halozyme Therapeutics P/E Ratio 2011-2024 | HALO

Annual P/E Ratio Halozyme Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
16.9 33.8 12.4 47.7 -38.8 -28.6 41.6 -13.9 -34.6 -25.6 -21.6 -14.7 -55.1

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
47.7 -55.1 -6.2